Green tea and its extracts may provide substantial benefit for body terrain factors, especially body weight, high blood sugar and insulin resistance, inflammation, oxidative stress, each of which is linked to cancer development and growth.

Are you a health professional?

This section does not replicate the other information on this topic but provides additional details or context most relevant to professionals.

Modes of action

“In addition to the inhibition of clonal expansion of cancer stem cells and the modulation of tumour progression by maintaining a quiescent state in cancer cells, green tea (EGCG) can modulate multiple cell signalling pathways implicated in angiogenesis, metastasis and invasion, such as the inhibition of matrix metalloproteinases (MMPs) and the inhibition of vascular endothelial growth factor (VEGF). EGCG has also been reported to inhibit activator protein 1 and MAPKs, cyclo-oxygenase-2 overexpression, proteasome activity, nitric oxide synthesis, HER-2/neu signalling, insulin-like growth factor-1 (IGF-1)-mediated signalling and nuclear factor-ĸB (NF-ĸB) signalling pathways. EGCG has been found to suppress the binding of epidermal growth factor (EGF) to its receptor, leading to the inhibition of EGF-mediated signal transduction pathways.”1Mokbel K, Mokbel K. Chemoprevention of breast cancer with vitamins and micronutrients: a concise review. In Vivo. 2019 Jul-Aug;33(4):983-997.

EGCG affects breast cancer cells by “restoring estrogen receptor gene expression, modulating epigenetic changes and events, and interfering with tumor growth rate.”2Gianfredi V, Vannini S et al. Sulforaphane and epigallocatechin gallate restore estrogen receptor expression by modulating epigenetic events in the breast cancer cell line MDA-MB-231: a systematic review and meta-analysis. Journal of Nutrigenetics and Nutrigenomics. 2017;10(3-4):126-135.

“This article reviews the cancer preventive activities and mechanisms of action of tea catechins involving their redox activities, biochemical properties and binding to key enzymes or signal transduction proteins.”3Liu C, Li P et al. Advances in the antagonism of epigallocatechin-3-gallate in the treatment of digestive tract tumors. Molecules. 2019 May 3;24(9). pii: E1726. 

Green tea catechins exert anticancer and chemopreventive effects by inhibiting the activation of specific RTKs, especially EGFR, IGF-1R, and VEGFR2.4Shimizu M, Adachi S, Masuda M, Kozawa O, Moriwaki H. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. Molecular Nutrition & Food Research. 2011 Jun;55(6):832-43. 

Improving treatment compliance

Some studies have found low levels of treatment compliance among people asked to drink several cups of green tea per day.5Dash C, Chung FL et al. A six-month crossover chemoprevention clinical trial of tea in smokers and non-smokers: methodological issues in a feasibility study. BMC Complementary and Alternative Medicine. 2012 Jul 16;12:96. Supplements may improve compliance for some individuals.

Preclinical evidence

Preclinical evidence is presented here; clinical evidence is summarized in How can green tea or EGCT help you? What the research says ›

Improving treatment outcomes

A 2017 review of preclinical studies found the weak inhibitory activity of EGCG increased synergistically in combination with anticancer drugs.6Fujiki H, Sueoka E, Rawangkan A, Suganuma M. Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate. Journal of Cancer Research and Clinical Oncology. 2017 Sep 23.

Brain cancer

A 2018 review found that EGCG enhances the effectiveness of several treatments with glioma:7Le CT, Leenders WPJ, Molenaar RJ, van Noorden CJF. Effects of the green tea polyphenol epigallocatechin-3-gallate on glioma: a critical evaluation of the literature. Nutrition and Cancer. 2018 Apr;70(3):317-333.

  • Irradiation
  • Some chemotherapy drugs: temozolomide, carmustine, cisplatin
  • Other cancer treatments: tamoxifen and TNF-related apoptosis-inducing ligand
Breast cancer

EGCG limits growth, proliferation and adhesion and induced cell death (apoptosis) of breast cancer cells.8Lewis KA, Jordan HR, Tollefsbol TO. Effects of SAHA and EGCG on growth potentiation of triple-negative breast cancer cells. Cancers (Basel). 2018 Dec 27;11(1). pii: E23; Avtanski D, Poretsky L. Phyto-polyphenols as potential inhibitors of breast cancer metastasis. Molecular Medicine. 2018 Jun 5;24(1):29.

Green tea catechins interact synergistically with tamoxifen or raloxifene, enhancing their use in treating estrogen receptor-positive and estrogen receptor-negative breast cancer, without interacting with aromatase inhibitors or fulvestrant in preclinical studies.9Yiannakopoulou EC. Interaction of green tea catechins with breast cancer endocrine treatment: a systematic review. Pharmacology. 2014;94(5-6):245-8.

Colorectal cancer

EGCG promoted cell death (apoptosis) and cell growth cycle arrest in human colon cancer cells.10Cerezo-Guisado MI, Zur R et al. Implication of Akt, ERK1/2 and alternative p38MAPK signalling pathways in human colon cancer cell apoptosis induced by green tea EGCG. Food and Chemical Toxicology. 2015 Oct;84:125-32.

Green tea polyphenols have anticancer effects on colon cells.11Hu G, Zhang L, Rong Y, Ni X, Sun Y. Downstream carcinogenesis signaling pathways by green tea polyphenols: a translational perspective of chemoprevention and treatment for cancers. Current Drug Metabolism. 2014 Jan;15(1):14-22; Ying L, Yan F et al. (-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells. Clinical and Experimental Pharmacology & Physiology. 2018 Jan;45(1):58-67; Ullah MF, Bhat SH et al. Pharmacological intervention through dietary nutraceuticals in gastrointestinal neoplasia. Critical Reviews in Food Science and Nutrition. 2016 Jul 3;56(9):1501-18.

Ovarian cancer

EGCG enhanced sensitivity of ovarian cancer cells to cisplatin.12Wang X, Jiang P et al. EGCG enhances cisplatin sensitivity by regulating expression of the copper and cisplatin influx transporter CTR1 in ovary cancer. PLoS One. 2015 Apr 30;10(4):e0125402.

Optimizing body terrain

Bleeding and coagulation imbalance

One polysaccharide in green tea has shown anticoagulation effects in cell studies.13Cai W, Xie L, Chen Y, Zhang H. Purification, characterization and anticoagulant activity of the polysaccharides from green tea. Carbohydrate Polymers. 2013 Feb 15;92(2):1086-90.

Helpful links for professionals

Centre for Health Innovation logo

Centre for Health Innovation: Professional Resource: Green
Tea ›

KNOW logo

KNOW Oncology › Subscription required

Keep reading about green tea or EGCG

Author

Nancy Hepp, MS

Lead Researcher
View profile

Ms. Hepp is a researcher and communicator who has been writing and editing educational content on varied health topics for more than 20 years. She serves as lead researcher and writer for CancerChoices and also served as the first program manager. Her graduate work in research and cognitive psychology, her master’s degree in instructional design, and her certificate in web design have all guided her in writing and presenting information for a wide variety of audiences and uses. Nancy’s service as faculty development coordinator in the Department of Family Medicine at Wright State University also provided experience in medical research, plus insights into medical education and medical care from the professional’s perspective.

Nancy Hepp, MS Lead Researcher

Reviewer

Andrew Jackson, ND

Research Associate
View profile

Andrew Jackson, ND, serves as a CancerChoices research associate. As a naturopathic physician practicing in Kirkland, Washington, he teaches critical evaluation of the medical literture at Bastyr University in Kenmore, Washington. His great appreciation of scientific inquiry and the scientific process has led him to view research with a critical eye.

Andrew Jackson, ND Research Associate

Last update: May 9, 2024

Last full literature review: January 2024

CancerChoices provides information about integrative in cancer care, a patient-centered approach combining the best of conventional care, self care and evidence-informed complementary care in an integrated plan cancer care. We review complementaryin cancer care, complementary care involves the use of therapies intended to enhance or add to standard conventional treatments; examples include supplements, mind-body approaches such as yoga or psychosocial therapy, and acupuncture therapies and self-care lifestyle actions and behaviors that may impact cancer outcomes; examples include eating health-promoting foods, limiting alcohol, increasing physical activity, and managing stress practices to help patients and professionals explore and integrate the best combination of conventionalthe cancer care offered by conventionally trained physicians and most hospitals; examples are chemotherapy, surgery, and radiotherapy and complementary therapies and practices for each person.

Our staff have no financial conflicts of interest to declare. We receive no funds from any manufacturers or retailers gaining financial profit by promoting or discouraging therapies mentioned on this site.

Learn more

Health professional comment

We invite health professionals to contribute expertise or send us questions.

"*" indicates required fields

Please share your thoughts about content on the CancerChoices website. If you have a correction for us to consider, or additional information to add, please include references and links if possible.

References[+]